fda compounding semaglutide warning letters october 2025 The sent a letter to the maker of Ozempic and Wegovy over unreported potential GLP-1 side effects. Here's what to know GLP-1 Drugs: FDA Removes Semaglutide

The glucagon receptor stimulation may also raise heart rate slightly, which is a separate concern, but the digestive implications are what matter for diarrhea specifically

2 additional categories are analyzed in the full comparison

But the next wave of therapies in development is focused on ease of administration, including oral options and less-frequent dosing

Obsessive-compulsive disorder (OCD): An RCT in 48 patients found that NAC (2,400 mg/day) as an add-on to fluvoxamine significantly improved Yale-Brown OCD Scale scores compared to placebo over 12 weeks (Afshar et al., J Clin Psychopharmacol, 2012) [72]

We will show you how to store your medication safelytypically in the refrigerator until use or at room temperature for a limited time as outlined in the product instructions